Amino Collective — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Anima is a gaming and interactive technology company that uses artificial intelligence to create virtual characters and worlds.
AI & Machine LearningConsumerGaming
Co-investorsCoinbase VenturesLD CapitalNarcissus VenturesYBB FoundationHummingbird VenturesMolten Ventures+1 more
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsBlueYard CapitalHAWKTAILMK Venture CapitalOctopus VenturesAcequia Capital (AceCap)redalpine+1 more
Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.
BiotechDeep TechCambridge, US
Floris Engelhardt(Executive Officer, Director)John Vroom(Director)
BoardAnn DeWitt(Director)in
Co-investorsFifty YearsLaunchpad Venture GroupMetaplanetThe Engine VenturesVsquared VenturesZAKA VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










